Innate immune responses in lupus-prone Palmerston North mice: Differential responses to lps and bacterial DNA/CpG oligonucleotides

Journal of Clinical Immunology

Volumn 23, Issue 3, 2003, Pages 202-213

  Lenert, Petar ^a   Goeken, Adam ^a   Handwerger, Barry S ^b   Ashman, Robert F ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

CpG; IL 10; IL 12; Lipopolysaccharide; SLE

Indexed keywords

BACTERIAL DNA; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; OLIGODEOXYRIBONUCLEOTIDE; OLIGONUCLEOTIDE; PROTEIN P40;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL CYCLE; CELL PROTECTION; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; FEMALE; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFECTION; LUPUS ERYTHEMATOSUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SECRETION; SPLEEN CELL; STATISTICAL SIGNIFICANCE; STRAIN IDENTIFICATION;

ANIMALS; CELLS, CULTURED; CPG ISLANDS; CYTOKINES; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTES; MICE; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN SUBUNITS; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 9;

EID: 0037406582     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023361912950     Document Type: Article

References (60)

1. Stacey KJ, Sweet MJ, Hume DA: Macrophages ingest and are activated by bacterial DNA. J Immunol 157:2116-2122, 1996
2. Yi A-K, Krieg AM: Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J Immunol 161:4493-4497, 1998
3. Jones BW, Means TK, Heldwein KA, Keen MA, Hill PJ, Belisle JT, Fenton MJ: Different toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol 69:1036-1044, 2001
4. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM: CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12 and interferon γ. J Immunol 93:2879-2883, 1996
5. Tokunaga T, Yamamoto H, Shamada S, Abe H, Fukuda T, Fujisawa Y, Farutani Y, Yano O, Kataoka T, Sudo T: Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst 72:955-962, 1984
6. Krieg AM, Yi A-K, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546-549, 1995
7. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A toll-like receptor recognizes bacterial DNA. Nature 408:740-745, 2000
8. Takeshita F, Leifer CA, Gursel I, Ishii KJ, Takeshita S, Gursel M, Klinman DM: Cutting edge: Role of toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 167:3555-3558, 2001
9. Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S, Wagner H, Lipford GB: Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 98:9237-9242, 2001
10. Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, Ballas ZK, Endres S, Krieg AM, Hartmann G: Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmocytoid dendritic cells. Eur J Immunol 31:2154-2163, 2001
11. Halpern MD, Kurlander RJ, Pisetsky DS: Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α. Cell Immunol 167:72-78, 1996
12. Jacob T, Walker PS, Krieg AM, Udey MC, Vogel JC: Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol 161:3042-3049, 1998
13. Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E., Yano O, Tokunaga T: Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J Immunol 148:4072-4076, 1992
14. Rothenfusser S, Hornung V, Krug A, Towarowski A, Krieg AM, Endres S, Hartmann G: Distinct CpG oligonucleotide sequences activate human γ δ T cells via interferon-α/-β. Eur J Immunol 31:3525-3534, 2001
15. Ballas ZK, Rasmussen WL, Krieg AM: Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 157:1840-1845, 1996
16. Kline JN, Waldschmidt TJ, Businga TR, Lemish JE, Weinstock JV, Thorne PS, Krieg AM: Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 160:2555-2559, 1998
17. Yi A-K, Chang M, Peckham DW, Krieg AM, Ashman RF: CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol 160:5898-5906, 1998
18. Stunz LL, Lenert P, Peckham D, Yi A-K, Haxhinasto S, Chang M, Krieg AM, Ashman RF: Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur J Immunol 32:1212-1222, 2002
19. Rhee SH, Hwang D: Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NFkB and expression of the inducible cyclooxygenase. J Biol Cbem 275:34035-34040, 2000
20. Zarember KA, Godowski PJ: Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products and cytokines. J Immunol 168:554-561, 2002
21. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187-191, 2000
22. Ogata H, Su I-h, Miyake K, Nagai Y, Akashi S, Mecklenbrauker I, Rajewsky K, Kimoto H, Tarakhovsky A: The Toll-like receptor protein RP105 regulates lypopolysaccharide signaling in B cells. J Exp Med 192:23-29, 2000
23. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-kB by Toll-like receptor 3. Nature 413:732-738, 2001
24. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DH, Aderem A: The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099-1103, 2001
25. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ: Peptidoglycan- and lipotechnoic acid-induced cell activation is mediated by Toll-like receptor 2. J Biol Chem 274:17406-17409, 1999
26. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, Tomizawa H, Takeda K, Akira S: Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nature Immunol 3:196-200, 2002
27. Horwitz DA, Gray JD, Behrendsen SC, Kubin M, Rengaraju M, Ohtsuka K, Trinchieri G: Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arth Rheum 41:838-844, 1998
28. Dean GS, Tyrell-Price J, Crawley E, Isenberg DA. Cytokines and systemic lupus erythematosus. Ann Rheum Dis 59:243-251, 2000
29. Alleva DG, Kaser SB, Beller DI:Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain. J Immunol 161:6878-6884, 1998
30. Min DJ, Cho ML, Cho CS, Min SY, Kim W-U, Yang SY, Min JK, Hong YS, Lee SH, Park SH, Kim HY: Decreased production of interleukin-12 and interferon-g is associated with renal involvement in systemic lupus erythematosus. Scand J Rheumatol 30:159-163, 2001
31. Zonana-Nacach A, Camargo-Coronel A, Yanez P, Sanchez L, Jimenez-Balderas FJ, Fraga A: Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus 10:505-510, 2001
32. Luzina IG, Knitzler RH, Atamas SP, Gause WC, Papadimitriou JC, Sztein MB, Storrer CE, Handwerger BS: Vasculitis in the Palmerston North mouse model of lupus: Phenotype and cytokine production profile of infiltrating cells. Arthritis Rheum 42:561-568, 1999
33. Lenert P, Stunz L, Yi A-K, Krieg AM, Ashman RF: CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleodites at a site proximal to NF-κB activation. Antisense Nucleic Acid Drug Dev 11:247-256, 2001
34. Traganos F, Darzynkiewicz Z, Sharpless T, Melamed MR: Simultaneous staining of ribonucleic acid and deoxyribonucleic acid in unfixed cells using acridine orange in a flow cytometric system. J Histochem Cytochem 25:46-56, 1977
35. Ma X, Trinchieri G: Regulation of interleukin-12 production in antigen-presenting cells. Adv Immunol 79:55-92, 2001
36. Verthelyi D, Ishii KJ, Gursel M, Takeshita F, Klinman DM: Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J Immunol 166:2372-2377, 2001
37. Linker-Israeli M, Honda M, Nand R, Mandyam R, Mengesha E, Wallace DJ, Metzger A, Beharter B, Klinenberg JR: Exogenous IL-10 and IL-4 down-regulate IL-6 production by SLE-derived PBMC. Clin Immunol 91:6-16, 1999
38. Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Fourrier MB, Brouet JC, Alarcon-Segovia A, Galanaud P: Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181:839-844, 1995
39. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M: Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179:305-310, 1994
40. Llorente L, Richaud-Patin Y, Garcia-Padilla C, Claret E, Jakez-Ocampo J, Cardiel MH, Alcocer-Varela J, Grangeot-Keros L, Alarcon-Segovia D, Wijdenes J, Galanaud P, Emilie D: Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arth Rheum 43:1790-1800, 2000
41. Lauwerys BR, Garot N, Ranauld JC, Houssiau FA: Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients. Arth Rheum 43:1976-1981, 2000
42. Tyrell-Price J, Lydyard PM, Isenberg DA: The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus. Clin Exp Immunol 124:118-125, 2001
43. Llorente L, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Maillot MC, Durand-Gasselin I, Fourrier BM, Galanaud P, Emilie D: Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 4:421-430, 1993
44. Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM, Galanaud P, Emilie D: In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus: A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arth Rheum 37:1647-1655, 1994
45. Hagiwara E, Gourley MF, Lee S, Klinman DM: Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-g-secreting cells in the peripheral blood. Arth Rheum 39:379-385, 1996
46. Amel-Kashipaz MR, Huggins ML, Lanyon P, Robins A, Todd I, Powel RJ: Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus. J Autoimmun 17:155-163, 2001
47. Csiszar A, Nagy G, Gergely P, Pozsonyi T, Pocsik E: Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 122:464-470, 2000
48. Grondal G, Gunnarsson I, Ronnelid J, Rogberg S, Klareskog L, Lundberg I: Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 18:565-570, 2000
49. Yin Z, Bahtiyar Gm Zhang N, Liu L, Zhu P, Robert ME, McNiff J, Madaio MP, Craft J: IL-10 regulates murine lupus. J Immunol 169:2148-2155, 2002
50. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765, 2001
51. Capsoni F, Minonzio F, Ongari AM, Carbonelli V, Galli A, Zanussi C: IL-10 up-regulates human monocyte phagocytosis in the presence of IL-4 and IFN-gamma. J Leukoc Biol 58:351-358, 1995
52. Gazzinelli RT, Oswald IP, James SL, Sher A: IL-10 inhibits parasite killing and nitric oxide production by IFN-γ-activated macrophages. J Immunol 148:1792-1796, 1992
53. Dalpke AH, Opper S, Zimmermann S, Heeg K: Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J Immunol 166:7082-7089, 2001
54. Krieg AM. CpG DNA: A pathogenic factor in systemic lupus erythematosus. J Clin Immunol 15:284-292, 1995
55. Gilkeson GS, Grudier JP, Karounos DG, Pisetsky DS: Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J Immunol 142:1482-1486, 1989
56. Gilkeson GS, Ruiz P, Pippen AM, Alexander AL, Lefkowith JB, Pisetsky DS: Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J Exp Med 183:1389-1397, 1996
57. Gilkeson GS, Conover J, Halpern M, Pisetsky DS, Feagin A, Klinman D: Effects of bacterial DNA on cytokine production by (NZB/NZW)F1 mice. J Immunol 161:3890-3895, 1998
58. Leadbetter EA, Rifkin AR, Hohlbaum AM, Beaudette BC, Schlomchik MJ, Marshak-Rothstein A: Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603-607, 2002
59. Chen Y, Lenert P, Weeratna R, McCluskie M, Wu T, Davis HL, Krieg AM: Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs. Gene Ther 8:1024-1032, 2001
60. Zeuner RA, Ishii KJ, Lizak MJ, Gursel I, Yamada H, Klinman DM, Verthelyi D: Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides. Arth Rheum 46:2219-2224, 2002